SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Fyodor Dostoevsky — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientFyodor Dostoevsky
Date of birth1821-11-11
IdentifiersMRN HR-NI018-SYN-TD; SSN (made up) 000-18-3907
Document date1865-07-07
AuthorAgnes Lindahl, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Four-month review of seizure control, mood, and gambling recovery. [S]

History of Present Illness

Mr. Dostoevsky returns four months after starting lamotrigine. He has had no seizure since the one in the third week of the titration, about sixteen weeks ago, including during the stomach illness last month, when he missed two doses. He has no side effects. He has not gambled for five months, although urges came back when an advance from his publisher arrived; he called his therapist and a friend instead. He has finished twelve therapy sessions and now goes every two weeks, and he attends Gamblers Anonymous most weeks. The debt repayment plan has started. He is planning a long research trip abroad in late summer. His mood is good. [S]

ElementDetail
SeizuresNone for about sixteen weeks
Lamotrigine100 mg twice daily; no side effects; two doses missed during the stomach illness
GamblingNone for five months; urges handled with his coping plan
PlansA long trip abroad in late summer

Review of Systems

SystemResultFinding
NeurologicalNegativeNo seizures, dizziness, double vision, or unsteadiness
IntegumentaryNegativeNo rash
PsychiatricNegativeMood good; occasional urges; no thoughts of suicide or self-harm

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Lamotrigine 25 mg tablets, slow titration: 25 mg once daily for weeks 1 and 2, 50 mg once daily for weeks 3 and 4, 50 mg twice daily for week 5, and 75 mg twice daily for week 625 mg once daily, increased every two weeks and then weekly as written, to 75 mg twice daily in week 6Oral route1865-03-03 to 1865-04-13completedS
Lamotrigine 100 mg tablet, one tablet twice daily100 mg twice daily (200 mg a day), 30-day supply at a timeOral route1865-04-14activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1865-07-07Body height170cmS
1865-07-07Body weight68.6kgS
1865-07-07Body mass index (BMI) [Ratio]23.7kg/m2S
1865-07-07Systolic blood pressure120mm[Hg]S
1865-07-07Diastolic blood pressure78mm[Hg]S
1865-07-07Heart rate70/minS
1865-07-07Respiratory rate14/minS
1865-07-07Body temperature36.6CelS
1865-07-07Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1865-07-07Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S

Physical Exam

Vital signs recorded on 1865-07-07; see the Vital Signs section. [S]

SystemFinding
GeneralWell; weight 68.6 kg; blood pressure 120/78, heart rate 70
NeurologicalNo nystagmus or ataxia
PsychiatricEuthymic and future-oriented

Problems

ProblemClinical statusVerificationCodeProvenance
Epilepsy of unknown type with recurrent generalized tonic-clonic seizures of unknown onset, untreated for many years; etiology unknownactiveconfirmed G40.909S — Synthetic modern coding of his documented epilepsy. The seizure type is left as unknown onset under the ILAE classification, because the retrospective classifications are disputed; no focal or generalized syndrome is coded.
Gambling disorder (roulette, in person and online), moderate, with debtsactiveconfirmed F63.0S — Synthetic modern coding of his documented compulsive roulette gambling.
Acute viral gastroenteritis with vomiting and two missed lamotrigine doses, without dehydration needing intravenous fluids; resolvedresolvedconfirmed A08.4S — Synthetic intercurrent illness at an unscheduled visit, chosen to teach missed antiseizure doses during vomiting; it does not echo a documented illness.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationSeizure frequency, seizure diary, and seizure descriptionEvery visitCompleted todayNo seizure for about sixteen weeks
Medication safetyAntiseizure medicine adverse effects (dizziness, double vision, unsteadiness, sleep, mood)Every visitCompleted todayNone
Medication safetyRash and mouth-sore check (lamotrigine)Every contact during titration and the first two months, then with symptomsNot indicatedPast the first two months without rash; asked only about symptoms
Medication safetyAdherence and missed dosesEvery visitCompleted todayTwo doses missed during the stomach illness last month; none otherwise
LaboratoryLamotrigine trough levelOnce at steady state as a reference, then with breakthrough seizures, suspected nonadherence, or interacting medicinesUp to dateReference level 6.2 ug/mL two months ago; no new indication
Self-managementTrigger review: sleep loss, alcohol, overwork, missed dosesEvery visitCompleted todaySleeping seven hours; travel and time-zone changes discussed as new risks
Self-managementSeizure safety and driving counselingAt diagnosis and every visitCompleted todayNot driving; precautions followed; travel safety discussed
Self-managementSUDEP discussionAt diagnosis and when seizure control changesUp to dateDiscussed with neurology four months ago; control has improved
SurveyDepression screen (PHQ-9)At intake, then every two to four months while symptoms are presentCompleted todayPHQ-9 5, item 9 scored 0
SurveySuicide-risk review and safety plan, with the 988 Suicide & Crisis LifelineEvery visit (gambling disorder and antiseizure-medicine labeling)Completed todayNo thoughts of suicide
SurveyGambling since the last visit: days, money lost, and urges (G-SAS for the past week)Every visitCompleted todayNo gambling for five months; G-SAS 8 for the past week
Self-managementCognitive behavioral therapy for gambling disorderWeekly sessions for at least 8 to 12 weeks, then as neededCompleted todayTwelve weekly sessions completed; now every two weeks; telehealth to be booked for the trip
Self-managementSelf-exclusion from casinos and online gamblingAt the start of treatment; renew and extend after any lapseUp to dateIn place at home; does not cover casinos abroad
Self-managementFinancial safeguards (bank gambling block, co-signer for large withdrawals, limited cash)At the start of treatmentUp to dateBank block and co-signer in place; set cash amount agreed for the trip
ReferralPeer support (Gamblers Anonymous)Offered at the start of treatment and after any lapseUp to dateAttends most weeks
ReferralDebt counselingOnce, early in treatmentUp to dateRepayment plan started
Medication safetyMedicine for gambling disorder (opioid antagonist)Considered if psychological treatment alone is not enoughNot indicatedResponding to psychological treatment
ReferralNeurology reviewIn January, or sooner after a breakthrough seizureUp to dateNext review in January

Goal progress:

Guideline basis: Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2015); Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy (2018); Psychological therapies for pathological and problem gambling (2012); Gambling disorder (2019); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)

Follow-up: Eight-month review after his trip. Call or message from abroad after any seizure. Next scheduled visit 1865-10-06: eight-month review after a breakthrough seizure and a gambling lapse while traveling. [S]